Inger von Bültzingslöwen

Summary

Affiliation: Central Hospital
Country: Sweden

Publications

  1. ncbi Patients' views on interpersonal continuity in primary care: a sense of security based on four core foundations
    Inger von Bültzingslöwen
    Swedish National Board of Health and Welfare, Goteborg, Sweden
    Fam Pract 23:210-9. 2006
  2. ncbi Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis
    Inger von Bültzingslöwen
    Department of Oral Medicine, Sahlgrenska Academy, Goteborg University, P O Box 450, 405 30, Goteborg, Sweden
    Support Care Cancer 14:519-27. 2006
  3. ncbi Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations
    Inger von Bültzingslöwen
    Department of Oral Medicine, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:S57.e1-15. 2007
  4. ncbi Combining paracetamol with a selective cyclooxygenase-2 inhibitor for acute pain relief after third molar surgery: a randomized, double-blind, placebo-controlled study
    Birgitta Haglund
    Public Dental Health Service, Karlstad, Värmland, Sweden
    Eur J Oral Sci 114:293-301. 2006

Detail Information

Publications4

  1. ncbi Patients' views on interpersonal continuity in primary care: a sense of security based on four core foundations
    Inger von Bültzingslöwen
    Swedish National Board of Health and Welfare, Goteborg, Sweden
    Fam Pract 23:210-9. 2006
    ..A deep and comprehensive understanding of what patients value about having a personal doctor in primary care is lacking...
  2. ncbi Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis
    Inger von Bültzingslöwen
    Department of Oral Medicine, Sahlgrenska Academy, Goteborg University, P O Box 450, 405 30, Goteborg, Sweden
    Support Care Cancer 14:519-27. 2006
    ..The aim of these evidence-based scientific reviews was to critically evaluate the literature and create evidence-based guidelines for the use of growth factors and cytokines in the prevention or treatment of CT- and RT-induced mucositis...
  3. ncbi Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations
    Inger von Bültzingslöwen
    Department of Oral Medicine, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:S57.e1-15. 2007
    ..The objective of this study was to identify systemic diseases associated with hyposalivation and xerostomia and develop evidence-based management recommendations for hyposalivation/xerostomia...
  4. ncbi Combining paracetamol with a selective cyclooxygenase-2 inhibitor for acute pain relief after third molar surgery: a randomized, double-blind, placebo-controlled study
    Birgitta Haglund
    Public Dental Health Service, Karlstad, Värmland, Sweden
    Eur J Oral Sci 114:293-301. 2006
    ..Whether this is relevant for short-term use is unknown, but it has to be considered before rofecoxib may be used for pain relief following third molar surgery...